CARTESIAN THERAPEUTICS INC.
NASDAQ: RNAC (Cartesian Therapeutics, Inc.)
Kemas kini terakhir: 19 jam lalu19.02
-0.25 (-1.30%)
| Penutupan Terdahulu | 19.27 |
| Buka | 18.96 |
| Jumlah Dagangan | 694,988 |
| Purata Dagangan (3B) | 132,096 |
| Modal Pasaran | 483,391,424 |
| Harga / Jualan (P/S) | 1.97 |
| Harga / Buku (P/B) | 642.47 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Mar 2025 - 10 Mar 2025 |
| Margin Operasi (TTM) | -4,541.34% |
| EPS Cair (TTM) | -55.43 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -94.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1,948.27% |
| Nisbah Semasa (MRQ) | 10.70 |
| Aliran Tunai Operasi (OCF TTM) | -39.96 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.93 M |
| Pulangan Atas Aset (ROA TTM) | -10.95% |
| Pulangan Atas Ekuiti (ROE TTM) | -7,029.26% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Cartesian Therapeutics, Inc. | Menurun | - |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | -2.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 5.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.40 |
|
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell’s genetic material. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 61.39% |
| % Dimiliki oleh Institusi | 27.85% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Mpm Bioimpact Llc | 30 Sep 2024 | 629,423 |
| Great Point Partners I Lp | 30 Sep 2024 | 200,000 |
| Erste Asset Management Gmbh | 30 Sep 2024 | 173,566 |
| Yale University | 30 Sep 2024 | 100,000 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 45.00 (HC Wainwright & Co., 136.59%) | Beli |
| Median | 42.00 (120.82%) | |
| Rendah | 41.00 (Needham, 115.56%) | Beli |
| Purata | 42.67 (124.34%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 20.45 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 19 Dec 2024 | 42.00 (120.82%) | Beli | 19.27 |
| HC Wainwright & Co. | 04 Dec 2024 | 45.00 (136.59%) | Beli | 22.00 |
| 08 Nov 2024 | 41.00 (115.56%) | Beli | 20.76 | |
| Needham | 03 Dec 2024 | 41.00 (115.56%) | Beli | 20.08 |
| 25 Nov 2024 | 41.00 (115.56%) | Beli | 17.91 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| KURTOGLU METIN | - | 23.62 | -13,664 | -329,112 |
| Jumlah Keseluruhan Kuantiti Bersih | -13,664 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -329,112 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 23.62 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| KURTOGLU METIN | Pegawai | 10 Dec 2024 | Jual (-) | 2,901 | 22.81 | 66,172 |
| KURTOGLU METIN | Pegawai | 10 Dec 2024 | Pelaksanaan pilihan | 2,901 | - | - |
| KURTOGLU METIN | Pegawai | 09 Dec 2024 | Jual (-) | 10,763 | 24.43 | 262,940 |
| KURTOGLU METIN | Pegawai | 09 Dec 2024 | Pelaksanaan pilihan | 10,763 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |